Buspirone is a clinically effective anxiolytic with a unique structure and pharma cology which
distinguishes it from the benzodiazepines. It has been termed anxioselective because it …

… Another study also assessed the pharmacokinetics and pharmacodynamics of buspirone …
buspirone is not clear. It is suggested that the main neuropharmacological effects of buspirone …

… buspirone to be effective in the treatment of anxiety, with efficacy comparable to cliazepam or
clorazepate. Buspirone … in rats, both buspirone and the benof buspirone derives from other …

… for the anti-anxiety effect of buspirone and that buspirone should be tested for efficacy in
various … of action for buspirone and MJ-13805 remains obscure. A metabolite of buspirone, 1-…

… Secondly, neither pentobarbital nor oxazepam generalized to buspirone in buspirone-trained
animals [15] (see Table 6). Thus, the preclinical pharmacology of buspirone supports the …

… buspirone with both oxazepam and pentobarbital,' rats trained to discriminate buspirone from
vehicle did not generalize the buspirone stimulus … to pentobarbital but not buspirone, while …

… Buspirone is a new nonbenzodiazepinic anxiolytic that is already being marketed in various
countries, including Italy; its neuropharmacological … study suggested that buspirone, at oral …

… was reversed by iontophoretic administration of buspirone, but buspirone did not interfere
with the ability of GABA to inhibit DA impulse flow. Buspirone did not cause catalepsy and did …

… buspirone than after the benzodiazepines; other side effects are minor and infrequent. In
healthy volunteers, buspirone … Early evidence suggests that buspirone has limited potential for …

… In early animal studies buspirone shared some pharmacologic properties with antipsychotics
(see Neuropharmacology). It was given to 10 schizophrenic patients, after 4-9 days of …